Literature DB >> 18256578

State of hypertension management in the United States: confluence of risk factors and the prevalence of resistant hypertension.

Pantelis A Sarafidis1, George L Bakris.   

Abstract

An improvement in the awareness and treatment of hypertension in the United States has occurred, resulting in the best control rates in the world, which unfortunately are far below the goals of Healthy People 2000 or 2010. This failure to achieve blood pressure (BP) goals is attributed to many factors, including an aging population, higher prevalence of kidney disease and obesity, high salt intake, physician inertia to increase dose and number of antihypertensive medications prescribed, and patient nonadherence with medication regimens. Resistant hypertension is defined as a failure to achieve goal BP in patients who adhere to full doses of an appropriate antihypertensive regimen of 3 drugs that includes a diuretic. The problem of resistant hypertension is projected to increase as the population ages. Efforts on the part of the Veterans Administration hospitals and others clearly indicate that a system can be implemented to help increase the percentage of persons in whom BP goal is achieved and reduce the prevalence of resistant hypertension. Medications specific to the problem of resistant hypertension are also under development. This review analyzes the status of hypertension control in the United States, the frequency of associated diseases, and adherence to guidelines; it further discusses strategies to reduce the prevalence of resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18256578      PMCID: PMC8110159          DOI: 10.1111/j.1751-7176.2008.07309.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  58 in total

1.  Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine.

Authors:  D J Hyman; V N Pavlik
Journal:  Arch Intern Med       Date:  2000 Aug 14-28

2.  Undertreatment of cardiovascular risk factors among persons with diabetes in the United States.

Authors:  Shaista Malik; Victor Lopez; Roland Chen; Wei Wu; Nathan D Wong
Journal:  Diabetes Res Clin Pract       Date:  2006-11-21       Impact factor: 5.602

3.  Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health.

Authors:  Barry D Dickinson; Stephen Havas
Journal:  Arch Intern Med       Date:  2007-07-23

Review 4.  Hypertension in America: a national reading.

Authors: 
Journal:  Am J Manag Care       Date:  2005-11       Impact factor: 2.229

5.  Differential effects of beta-blockers on albuminuria in patients with type 2 diabetes.

Authors:  George L Bakris; Vivian Fonseca; Richard E Katholi; Janet B McGill; Franz Messerli; Robert A Phillips; Philip Raskin; Jackson T Wright; Brian Waterhouse; Mary Ann Lukas; Karen M Anderson; David S H Bell
Journal:  Hypertension       Date:  2005-11-14       Impact factor: 10.190

6.  Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.

Authors:  George L Bakris; Matthew R Weir; Shahnaz Shanifar; Zhongxin Zhang; Janice Douglas; David J van Dijk; Barry M Brenner
Journal:  Arch Intern Med       Date:  2003-07-14

Review 7.  Diabetes and chronic kidney disease: tragedy and challenge.

Authors:  Dave Y Chua; George L Bakris
Journal:  Blood Purif       Date:  2004       Impact factor: 2.614

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Prevalence, awareness, treatment and control of hypertension in employees of factories of Northern Greece: the Naoussa study.

Authors:  P A Sarafidis; A Lasaridis; S Gousopoulos; P Zebekakis; P Nikolaidis; I Tziolas; F Papoulidou
Journal:  J Hum Hypertens       Date:  2004-09       Impact factor: 3.012

10.  Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey.

Authors:  Josef Coresh; Brad C Astor; Tom Greene; Garabed Eknoyan; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2003-01       Impact factor: 8.860

View more
  35 in total

1.  The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

2.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin Exp Nephrol       Date:  2009-01-28       Impact factor: 2.801

3.  Hypertension: the message of World Kidney Day 2009.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

4.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

5.  Interventional cardiology: Indications for renal denervation: a balanced approach?

Authors:  George L Bakris
Journal:  Nat Rev Cardiol       Date:  2013-06-04       Impact factor: 32.419

Review 6.  Management of Resistant Hypertension Based on Recommendations from Different Guidelines and the Systolic Blood Pressure Intervention Trial.

Authors:  Sandeep Banga; Sudhir Mungee; Avani R Patel; Shantanu Singh; Tinoy J Kizhakekuttu
Journal:  Cureus       Date:  2019-08-12

Review 7.  Fetal programming and the angiotensin-(1-7) axis: a review of the experimental and clinical data.

Authors:  Andrew M South; Hossam A Shaltout; Lisa K Washburn; Alexa S Hendricks; Debra I Diz; Mark C Chappell
Journal:  Clin Sci (Lond)       Date:  2019-01-08       Impact factor: 6.124

Review 8.  Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Authors:  Hamish Cg Prosser; Cynthia Gregory; Dagmara Hering; Graham S Hillis; Greg Perry; Johan Rosman; Carl Schultz; Mark Thomas; Gerald F Watts; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

9.  Sugar-sweetened beverages and school students' hypertension in urban areas of Nanjing, China.

Authors:  Zhenzhen Qin; Fei Xu; Qing Ye; Hairong Zhou; Chao Li; Jing He; Zhiyong Wang; Xin Hong; Xiangyu Hou
Journal:  J Hum Hypertens       Date:  2018-02-06       Impact factor: 3.012

Review 10.  Role of ambulatory blood pressure monitoring in hypertension and diabetes.

Authors:  Colleen Flynn; George L Bakris
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.